Cathie Wood’s ARK ETFs buy AMD and CRISPR, sell Palantir stock

Published 08/05/2025, 01:04
© REUTERS

Cathie Wood’s ARK ETFs have published their daily trades for Wednesday, May 7th, 2025, revealing a series of significant transactions in the tech and biotech sectors. The largest dollar-value trade of the day came from the sale of Palantir Technologies Inc (NYSE:NASDAQ:PLTR), with ARK divesting a total of 351,340 shares across its various funds, amounting to a substantial $38,246,872.

On the buying side, ARK showed a strong interest in NVIDIA Corp (NASDAQ:NVDA), purchasing a total of 107,661 shares valued at $12,223,829. This move suggests a growing confidence in the semiconductor industry, as ARK also increased its stake in Advanced Micro Devices Inc (NASDAQ:AMD) with a total of 114,581 shares bought, totaling $11,299,978. The investment in AMD marks a continuation of ARK’s recent accumulation of the stock, indicating a strategic position in the chipmaker.

Another significant investment was made in CRISPR Therapeutics AG (NASDAQ:CRSP), with ARK buying 328,825 shares for a total of $10,903,836. This trade underscores ARK’s ongoing interest in the gene-editing company, as seen by previous trades.

Additional trades included a purchase of 46,400 shares of GitLab Inc (NASDAQ:GTLB) for $2,157,136 and 7,891 shares of Natera Inc (NASDAQ:NTRA) for $1,227,050, reflecting ARK’s keen eye on the tech sector’s growth potential. Moreover, ARK added 75,020 shares of Tempus AI Inc (NYSE:TEM) to its holdings, with a dollar value of $3,915,293.

Smaller-scale trades involved Pacific Biosciences of California Inc (NASDAQ:PACB) and 10X Genomics Inc (NASDAQ:TXG), with ARK purchasing 194,298 and 18,177 shares respectively, totaling $213,727 and $147,233.

The day’s sell trades were not limited to Palantir, as ARK also reduced its position in Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) by selling 95,502 shares worth $1,073,442.

ARK’s trading activity demonstrates a strategic balancing act between sectors, with a clear focus on innovative companies poised for growth. Investors interested in ARK’s movements should note these patterns as they may signal the funds’ long-term investment strategies.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.